What is Proximie?
Founded in 2016 and headquartered in London, United Kingdom, Proximie operates as a global health technology platform dedicated to the digitization of operating and diagnostic rooms. The company's core mission is to save lives by facilitating the sharing of the world's best clinical practice. Each Proximie procedure can be recorded, analyzed, and leveraged for future use, thereby informing and improving best practices in healthcare delivery. This focus on data-driven clinical improvement positions Proximie as a key player in the digital health transformation.
How much funding has Proximie raised?
Proximie has raised a total of $118M across 2 funding rounds:
Series B
$38M
Series C
$80M
Series B (2021): $38M with participation from F-Prime Capital Partners, Global Ventures, Cedar Mundi Ventures, Questa Capital, BECO Capital, Eight Roads, and Maverick Ventures
Series C (2022): $80M led by The Minderoo Foundation, Mubadala, Advent Venture Partners, British Patient Capital, Emerson Collective, and SoftBank Vision Fund 2
Key Investors in Proximie
The Minderoo Foundation
The Minderoo Foundation is a philanthropic organization focused on driving positive, lasting change across various initiatives, including health and medical research, indicating a strategic interest in impactful health technology.
Mubadala
Mubadala is a global investment company based in Abu Dhabi, with a mandate to create sustainable financial returns, suggesting a focus on growth-stage companies with strong market potential.
Advent Venture Partners
Advent Venture Partners LLP operates in the Venture Capital & Private Equity industry, specializing in investments in technology-driven companies, aligning with Proximie's innovative health technology focus.
What's next for Proximie?
The significant enterprise-level funding secured by Proximie, particularly the recent Series C round, indicates a strategic pivot towards scaling its operations and expanding its global reach. This substantial capital injection is expected to fuel further technological development, enhance its platform capabilities, and accelerate market penetration in key healthcare regions. Proximie's ability to attract major investors like The Minderoo Foundation and Mubadala suggests a strong market validation and a clear path towards achieving its objective of digitizing surgical procedures worldwide, ultimately aiming to improve patient outcomes and democratize access to expert medical knowledge.
See full Proximie company page
